GLOPID-R

Highlight Event: European Research and Innovation Days – September 24 26, 2019

European Research and Innovation Days is the first annual policy event of the European Commission, bringing together stakeholders to debate and shape the future research and innovation landscape.

Aim of the event

A key challenge for Europe is delivering the next great transition of our economy, society and planet to secure a sustainable future that ensures the wellbeing of citizens. The event will be central to finding research and innovation solutions for this great transition by working across polices, setting the direction, spurring innovation and triggering investment. It will be the moment for all stakeholders to meet and co-create the strategic priorities for the European Commission’s investment in research and innovation. At the same time, the event aims to mobilize EU citizens and increase awareness of how important research and innovation are in addressing the challenges that face society.

Sessions related to infectious diseases

  • Tackling infectious diseases & anti-microbial resistance
    This session will focus on infectious diseases including the high death toll of poverty related diseases, the threats of emerging infectious ones and the rising impact of antimicrobial resistance.
    Room 1, 25/09/2019 from 16:00-17:00
  • Health systems: from research output to societal impact
    Reforming health and care systems is a priority addressed at every governance level. Yet, efforts are fragmented,uncoordinated and need to be upscaled. We will debate how to create a continued innovation cycle to translate research output into societal impact.
    Room 5, 26/09/2019 from 11:00-12:00
  • Healthy environment, healthy people
    A glimpse of the public perception of the future environment and health policy, and relevant research challenges, to feed into the development of a dedicated Research&Innovation agenda
    Room 7, 24/09/2019 from14:30-15:30

Read more

EU Flag

The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874667.